A year into the 10-Year Cancer Care Action Plan to build capacity and expand access to cancer-care services to meet growing demand, more people in B.C. are benefiting from expanded… Read More
SILVER SPRING, MD & RESEARCH TRIANGLE PARK, NC – United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced the addition of former Minnesota Commissioner of Health Jan Malcolm to its Board of… Read More
Neuroscientist John McDonald, archaeological scientist Michael Richards and computational chemist Samira Siahrostami’s appointments were announced June 14 by the federal government. These scholars advance Canadian research excellence in a range… Read More
Renowned, experienced industry leader in newly created role for Cytiva Ruffieux joins Cytiva executive team on 1 July 2024 Cytiva is strengthening its leadership team with one of the biotechnology… Read More
Celsius’ CEL383 is a potential first-in-class anti-Triggering Receptor Expressed on Myeloid Cells 1 (TREM1) antibody for the treatment of inflammatory bowel disease (IBD) NORTH CHICAGO, IL – AbbVie (NYSE: ABBV) announced… Read More
